QDIS Blog

A blog about chemistry, drug development, science, and technology

Pages (999999): [1] 2 3 » ... Last »

May 15, 2006

Astrazenaca to buy Cambridge Antibody Technology (CAT)

by @ 12:35 pm.  Filed under Pharma News

Interesting news that Astrazenaca is to buy Cambridge Antibody Technology (CAT) for $1.3 billion. It will be interesting to see the fall out from this since CAT is working on a variety of projects for other pharma/biotech companies such as Genzyme. Here’s a list of CAT’s partners. Some of the larger players are Abbott, Human Genome Sciences, Merck, and Pfizer. Having been involved with a contract manufacturer who was bought by a competitor I can tell you there are some people who are scrambling to figure out a backup plan. There will definitely be some turmoil for a while but this may open the door to other antibody manufactures to possibly lure CAT’s partners away or at least be given serious consideration is a second source. It will be interesting to see how this develops.

Technorati Tags:

Email Ed Vawter



Related Posts:
  • GlaxoSmithKline To Acquire Domantis
  • Genentech and Seattle Genetics Announce Agreement for SGN-40
  • More Mergers with Pfizer Snatching Up Powdermed
  • Acambis a Takeover Target?
  • Merck Buys Sirna Biotech

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Pharma and Google trends

    by @ 11:28 am.  Filed under Search Tips, Technology, Pharma

    Google Trends is an interesting tools to see trends in what people are searching for on Google. I decided to do a little investigation on some items of interest to the drug industry.

    1. Vioxx: I looked at the trends for “Vioxx”and the results spike at the end of Sept 2004 when Merck announced they were withdrawing the drug from the market. It’s been relatively flat since.

    200605151105

    2. If you limit the results to just the US, it is interesting that the number one city searching for Vioxx was Barnwell, SC (population 24,000), So I was curious as to why such a small town in SC would be by far and away the largest searcher for the term Vioxx. A quick search for “vioxx” and Barnwell yields the answer; one of the law firms involved in the Vioxx case in NJ was Weitz & Luxenberg and they have offices in Barnwell, SC. They also have offices in Mannford, OH.

    200605151102

    3. Search for “Plan B” has also seen a trend up. Unfortunately, Google trends doesn’t list any news items for this term.

    200605151108

    4. A Search for “FDA” shows that there are more than twice as many searches for this term in India than in the US. This isn’t surprising since India is a growing market for pharmaceutical products, active pharmaceutical ingredients (API) and other related services.
    200605151115

    If we limit it to the US, then Rockville, MD is the number one city, not surprising since that’s where the FDA headquarters are located.

    200605151135

    I’m sure there may be even more interesting results after I’ve had time to play with it more. Also, keep in mind that uncommon search terms don’t give good results.

    Technorati Tags: ,

    Email Ed Vawter



    Related Posts:
  • Encysive To Evaluate Options
  • The FDA and Nanotechnology
  • Latest in pharma layoffs
  • Another Major Merger: Schering-Plough to Acquire Organon BioSciences for $14.4 Billion
  • My thoughts on Google Buying YouTube

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    The FDA and Biogenerics follow up

    by @ 7:00 am.  Filed under FDA

    After posting my entry on Biogenerics and the FDA, I came across another excellent article in PharmaManufacturing entitled A Wave, Suspended: Follow-on Biologics. I can highly recommend this article. It gives a very good insight and does a better job of explaining the situation than I did.
    Technorati Tags:

    Email Ed Vawter



    Related Posts:
  • More on Biotech Generics
  • Pfizer to Cut 2,200 Marketing Jobs
  • Sandoz gets precedent-setting US approval for Omnitrope®
  • No Generic biologics in FDA legislation
  • Follow-up on Pliva Being Acquired

  • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Pages (999999): [1] 2 3 » ... Last »

    [powered by WordPress.]

    QDIS: blogging about chemistry, drug development, science and technology.

    Internal Links

    Categories

    Search This Blog

    Archives

    May 2006
    S M T W T F S
    « Apr   Jun »
     123456
    78910111213
    14151617181920
    21222324252627
    28293031  

    Search Entire Site

    Subscribe (It's Free!)

    Performancing

    Chemistry, science, and technology for the future.

    logo2

    General Links

    Blog Links

    Chemistry Journal Feeds

    Chemistry Feeds

    47 queries. 1.263 seconds